Evidence map›Paper›PMID 14989411›Full record

ArticleSchizophrenia bulletin2003

Overcoming barriers to research in early serious mental illness: issues for future collaboration.

Robert K Heinssen, Bruce N Cuthbert, James Breiling, Lisa J Colpe, Regina Dolan-Sewell

Abstract read
PubMed Publisher
In one paragraph

Article in Schizophrenia bulletin, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Treating early psychosis: who, what, and when?Dialogues in clinical neuroscience · 2005
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Robert K HeinssenOffice of Prevention, National Institute of Mental Health, and Division of Mental Disorders, Behavioral Research, and AIDS, Bethesda, MD 20892-9625, USA. rheinsse@mail.nih.gov
Bruce N Cuthbert
James Breiling
Lisa J Colpe
Regina Dolan-Sewell

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several methodological barriers impede discovery of early illness pathways in schizophrenia, including small samples, elongated study periods, and failure to integrate procedures and data across prodromal and first episode projects. A compounding factor is the tendency for single-site studies to focus narrowly on schizophrenia risk factors, rather than exploring vulnerability mechanisms that may cut across DSM-IV boundaries. To address these concerns, we discuss the merits of an integrated multisite approach to research that promotes large-scale investigation into the earliest phases of serious mental illness. The distinctive characteristics of this collaborative approach to early serious mental illness research could include (1) subject recruitment across several sites; (2) a broad diagnostic focus; (3) a core clinical and neuroscience assessment protocol; (4) longitudinal evaluation of subjects through a range of outcomes; and (5) an iterative approach to psychopathology research. This model represents a method for exploring prodromal phenotypes, for discovering causal risk mechanisms, and for investigating the biological and environmental interactions that define the early course of several disorders, including schizophrenia, bipolar illness, and borderline personality disorder. This strategy could speed discovery of clinical tools most relevant to the earliest stages of serious mental illness; i.e., better methods of screening, diagnosing, and treating mental disorders before symptoms and impairments solidify into chronic disabilities.

Indexed as

Cooperative BehaviorInterprofessional RelationsResearchAdolescentAdultChildHumansLongitudinal StudiesMulticenter Studies as TopicPatient Care TeamRisk FactorsSchizophreniaSchizotypal Personality Disorder

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.